Added Value of Cognition in the Prediction of Survival in Low and High Grade Glioma
Background: Diffuse gliomas, which are at WHO grade II-IV, are progressive primary brain tumors with great variability in prognosis. Our aim was to investigate whether pre-operative cognitive functioning is of added value in survival prediction in these patients.Methods: In a retrospective cohort st...
Guardado en:
Autores principales: | Emma van Kessel, Ewoud Schuit, Irene M. C. Huenges Wajer, Carla Ruis, Filip Y. F. L. De Vos, Joost J. C. Verhoeff, Tatjana Seute, Martine J. E. van Zandvoort, Pierre A. Robe, Tom J. Snijders |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f5fe308b91034fba9bfa10e59f1b0199 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Glioma nasal gigante: reporte de un caso
por: Medel B,Simón, et al.
Publicado: (2015) -
Glioma multifocal multicéntrico
por: Guerrero T,Rodrigo, et al.
Publicado: (2010) -
Glioma difuso de línea media H3K27M positivo en adulto. Caso clínico
por: ARANEDA,PATRICIA, et al.
Publicado: (2019) -
Delivery luteolin with folacin-modified nanoparticle for glioma therapy
por: Wu C, et al.
Publicado: (2019) -
Accurately Controlled Delivery of Temozolomide by Biocompatible UiO-66-NH2 Through Ultrasound to Enhance the Antitumor Efficacy and Attenuate the Toxicity for Treatment of Malignant Glioma
por: Wan Z, et al.
Publicado: (2021)